cvot tirzepatide cardiovascular outcomes In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide Tirzepatide Demonstrates Cardioprotective Effects in

doi: 10.1186/s13643-021-01626-4 25 OuzzaniMHammadyHFedorowiczZElmagarmidA

Reduce your intake of heavy, greasy, or overly fatty foods, which slow your digestion down even further

Administered via self-injection, these chemicals are claimed to result in thicker hair, increased libido, greater muscle mass, better skin, heightened focus, and more

Larger needles create faster tissue penetration but more mechanical irritation

A 10 mg vial is ideal for the titration phase when weekly doses are small (2-4 mg), because the vial gets used within its optimal potency window

Your provider can advise whether it makes sense for your situation